Delivery Order SPE2DB24D1205-SPE2DB24FCTHB
Award Date
8/1/24
Potential Completion Date
8/2/24
Potential Value
$5.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,406.98, is for the supply of 4,567,480 units of the pharmaceutical product Glipizide ER 5 mg Tablets. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $8,665.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,176,341 units of the prescription drug Glipizide ER 10 mg tablets. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GLIPIZIDE ER 10 MG TABLET 500S. The contract has a firm fixed price of $2,465.34 and runs through January 30, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,456.86, is for the delivery of 4,564,711,682 units of the drug glipizide extended-release 10 mg tablets. The contract has a firm fixed price and an ultimate completion date of May 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order under contract SPE2DX15D1205 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,509.18 award is for 1,000 tablets of Glipizide ER 10 mg, a medication used to treat diabetes. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract with the DLA, which provides a comprehensive range of...
This federal contract award, valued at $1,806.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glipizide ER 5 mg Tablets in quantities of 1,000 tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of July 10, 2024. This award does not utilize any set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $5,680.12, is for the supply of glipizide ER 10 mg tablets. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Glipizide ER 5 mg tablets. The fixed-price delivery order, valued at $1,360.48, has an ultimate completion date of August 15, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,103.28, is a Firm Fixed Price Delivery Order for the supply of GLIPIZIDE ER 10 MG TABLET 500S. The contract has an ultimate completion date of January 23, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not designated as a set-aside contract. The company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,840.94 firm-fixed-price delivery order is for the supply of 4,564,996,919 units of the drug Glipizide ER 5 mg tablets. The contract has an ultimate completion date of June 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...